|
| Publications [#175709] of Kam W. Leong
Papers Published
- Haider, M. and Cappello, J. and Ghandehari, H. and Leong, K. W., In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels,
Pharmaceutical Research, vol. 25 no. 3
(2008),
pp. 692-699
(last updated on 2010/06/11)
Abstract:
Purpose. In this study the chondrocytic differentiation and cartilage matrix accumulation of human mesenchymal stem cells (hMSCs) were investigated after encapsulation in a genetically engineered silk-elastinlike protein polymer SELP-47 K as an injectable matrix for delivery of cell-based therapeutics. Materials and Methods. hMSCs were encapsulated in SELP-47 K and cultured for 4 weeks in chondrogenic medium with or without transforming growth factor-beta 3 (TGF). Chondrogenic differentiation was evaluated by histological, RNA and biochemical analyses for the expression of cartilage extracellular matrix components. Results. Histological and immunohistochemical staining revealed that the cells acquired a rounded morphology and were embedded in significant amounts of chondrogenic extracellular matrix. Reverse transcriptase (RT)-PCR showed an up-regulation in aggrecan, type II and type X collagen and SOX9 in presence of TGF-beta 3. By day 28, constructs cultured in the presence of TGF-beta 3 exhibited significant increase in sulfated glycosaminoglycan and total collagen content up to 65 and 300%, respectively. Conclusions. This study demonstrates that SELP-47 K hydrogel can be used as a scaffold for encapsulation and chondrogenesis of hMSCs. The ability to use recombinant techniques to precisely control SELP structure enables the investigation of injectable protein polymer scaffolds for soft-tissue engineering with varied physicochemical properties.
Keywords:
chondrogenesis genetically engineered polymers hydrogels silk-elastinelike polymers tissue engineering protein polymer bone-marrow articular-cartilage controlled-release drug-delivery tissue-repair gene-therapy matrix differentiation polypeptide
|
